305 related articles for article (PubMed ID: 24727978)
1. A cannabigerol derivative suppresses immune responses and protects mice from experimental autoimmune encephalomyelitis.
Carrillo-Salinas FJ; Navarrete C; Mecha M; Feliú A; Collado JA; Cantarero I; Bellido ML; Muñoz E; Guaza C
PLoS One; 2014; 9(4):e94733. PubMed ID: 24727978
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia mimetic activity of VCE-004.8, a cannabidiol quinone derivative: implications for multiple sclerosis therapy.
Navarrete C; Carrillo-Salinas F; Palomares B; Mecha M; Jiménez-Jiménez C; Mestre L; Feliú A; Bellido ML; Fiebich BL; Appendino G; Calzado MA; Guaza C; Muñoz E
J Neuroinflammation; 2018 Mar; 15(1):64. PubMed ID: 29495967
[TBL] [Abstract][Full Text] [Related]
3. Mannan-MOG35-55 Reverses Experimental Autoimmune Encephalomyelitis, Inducing a Peripheral Type 2 Myeloid Response, Reducing CNS Inflammation, and Preserving Axons in Spinal Cord Lesions.
Dagkonaki A; Avloniti M; Evangelidou M; Papazian I; Kanistras I; Tseveleki V; Lampros F; Tselios T; Jensen LT; Möbius W; Ruhwedel T; Androutsou ME; Matsoukas J; Anagnostouli M; Lassmann H; Probert L
Front Immunol; 2020; 11():575451. PubMed ID: 33329540
[TBL] [Abstract][Full Text] [Related]
4. Benefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation-driven neuronal deterioration in experimental Parkinson's disease: possible involvement of different binding sites at the PPARγ receptor.
García C; Gómez-Cañas M; Burgaz S; Palomares B; Gómez-Gálvez Y; Palomo-Garo C; Campo S; Ferrer-Hernández J; Pavicic C; Navarrete C; Luz Bellido M; García-Arencibia M; Ruth Pazos M; Muñoz E; Fernández-Ruiz J
J Neuroinflammation; 2018 Jan; 15(1):19. PubMed ID: 29338785
[TBL] [Abstract][Full Text] [Related]
5. Silencing c-Rel in macrophages dampens Th1 and Th17 immune responses and alleviates experimental autoimmune encephalomyelitis in mice.
Zhang H; Bi J; Yi H; Fan T; Ruan Q; Cai L; Chen YH; Wan X
Immunol Cell Biol; 2017 Aug; 95(7):593-600. PubMed ID: 28202908
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic effect of baicalin on experimental autoimmune encephalomyelitis is mediated by SOCS3 regulatory pathway.
Zhang Y; Li X; Ciric B; Ma CG; Gran B; Rostami A; Zhang GX
Sci Rep; 2015 Nov; 5():17407. PubMed ID: 26616302
[TBL] [Abstract][Full Text] [Related]
7. Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS.
Kong W; Li H; Tuma RF; Ganea D
Cell Immunol; 2014 Jan; 287(1):1-17. PubMed ID: 24342422
[TBL] [Abstract][Full Text] [Related]
8. An Oriental Medicine, Hyungbangpaedok-San Attenuates Motor Paralysis in an Experimental Model of Multiple Sclerosis by Regulating the T Cell Response.
Choi JH; Lee MJ; Jang M; Kim EJ; Shim I; Kim HJ; Lee S; Lee SW; Kim YO; Cho IH
PLoS One; 2015; 10(10):e0138592. PubMed ID: 26444423
[TBL] [Abstract][Full Text] [Related]
9. Fasudil regulates T cell responses through polarization of BV-2 cells in mice experimental autoimmune encephalomyelitis.
Chen C; Li YH; Zhang Q; Yu JZ; Zhao YF; Ma CG; Xiao BG
Acta Pharmacol Sin; 2014 Nov; 35(11):1428-38. PubMed ID: 25263338
[TBL] [Abstract][Full Text] [Related]
10. Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation.
Ingwersen J; Wingerath B; Graf J; Lepka K; Hofrichter M; Schröter F; Wedekind F; Bauer A; Schrader J; Hartung HP; Prozorovski T; Aktas O
J Neuroinflammation; 2016 Feb; 13():48. PubMed ID: 26920550
[TBL] [Abstract][Full Text] [Related]
11. Korean Red Ginseng and Ginsenoside-Rb1/-Rg1 Alleviate Experimental Autoimmune Encephalomyelitis by Suppressing Th1 and Th17 Cells and Upregulating Regulatory T Cells.
Lee MJ; Jang M; Choi J; Chang BS; Kim DY; Kim SH; Kwak YS; Oh S; Lee JH; Chang BJ; Nah SY; Cho IH
Mol Neurobiol; 2016 Apr; 53(3):1977-2002. PubMed ID: 25846819
[TBL] [Abstract][Full Text] [Related]
12. Novel disease-modifying anti-rheumatic drug iguratimod suppresses chronic experimental autoimmune encephalomyelitis by down-regulating activation of macrophages/microglia through an NF-κB pathway.
Li G; Yamasaki R; Fang M; Masaki K; Ochi H; Matsushita T; Kira JI
Sci Rep; 2018 Jan; 8(1):1933. PubMed ID: 29386552
[TBL] [Abstract][Full Text] [Related]
13. The therapeutic potential of Rho kinase inhibitor fasudil derivative FaD-1 in experimental autoimmune encephalomyelitis.
Zhao YF; Zhang X; Ding ZB; Yang XW; Zhang H; Yu JZ; Li YH; Liu CY; Zhang Q; Zhang HZ; Ma CG; Xiao BG
J Mol Neurosci; 2015 Mar; 55(3):725-32. PubMed ID: 25223373
[TBL] [Abstract][Full Text] [Related]
14. Conditional ablation of astroglial CCL2 suppresses CNS accumulation of M1 macrophages and preserves axons in mice with MOG peptide EAE.
Moreno M; Bannerman P; Ma J; Guo F; Miers L; Soulika AM; Pleasure D
J Neurosci; 2014 Jun; 34(24):8175-85. PubMed ID: 24920622
[TBL] [Abstract][Full Text] [Related]
15. T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.
Zheng H; Zhang H; Liu F; Qi Y; Jiang H
Immunol Lett; 2014; 157(1-2):38-44. PubMed ID: 24220208
[TBL] [Abstract][Full Text] [Related]
16. Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice.
Kozela E; Lev N; Kaushansky N; Eilam R; Rimmerman N; Levy R; Ben-Nun A; Juknat A; Vogel Z
Br J Pharmacol; 2011 Aug; 163(7):1507-19. PubMed ID: 21449980
[TBL] [Abstract][Full Text] [Related]
17. Phosphodiesterase 5 inhibition at disease onset prevents experimental autoimmune encephalomyelitis progression through immunoregulatory and neuroprotective actions.
Pifarré P; Gutierrez-Mecinas M; Prado J; Usero L; Roura-Mir C; Giralt M; Hidalgo J; García A
Exp Neurol; 2014 Jan; 251():58-71. PubMed ID: 24211383
[TBL] [Abstract][Full Text] [Related]
18. Kirenol attenuates experimental autoimmune encephalomyelitis by inhibiting differentiation of Th1 and th17 cells and inducing apoptosis of effector T cells.
Xiao J; Yang R; Yang L; Fan X; Liu W; Deng W
Sci Rep; 2015 Mar; 5():9022. PubMed ID: 25762107
[TBL] [Abstract][Full Text] [Related]
19. The flavonoid kurarinone inhibits clinical progression of EAE through inhibiting Th1 and Th17 cell differentiation and proliferation.
Xie L; Gong W; Chen J; Xie HW; Wang M; Yin XP; Wu W
Int Immunopharmacol; 2018 Sep; 62():227-236. PubMed ID: 30031314
[TBL] [Abstract][Full Text] [Related]
20. Pituitary adenylate cyclase-activating polypeptide (PACAP) ameliorates experimental autoimmune encephalomyelitis by suppressing the functions of antigen presenting cells.
Kato H; Ito A; Kawanokuchi J; Jin S; Mizuno T; Ojika K; Ueda R; Suzumura A
Mult Scler; 2004 Dec; 10(6):651-9. PubMed ID: 15584490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
